Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

38.50
+0.35000.92%
Post-market: 38.500.00000.00%19:30 EDT
Volume:486.07K
Turnover:18.71M
Market Cap:2.24B
PE:12.46
High:38.93
Open:38.13
Low:37.48
Close:38.15
52wk High:40.87
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:0.80
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.24
PE(LYR):14.21

Loading ...

Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed?

Simply Wall St.
·
Apr 22

Harmony Biosciences : Oppenheimer Raises Target Price to $72 From $62

THOMSON REUTERS
·
Apr 22

Harmony Biosciences to present Phase 3 ARGUS extension data for EPX-100 in Dravet syndrome

Reuters
·
Apr 16

Harmony Biosciences reiterates 2026 net product revenue guidance of $1-1.04 billion

Reuters
·
Apr 14

Harmony Biosciences appoints Glenn Reicin as CFO

Reuters
·
Apr 14

Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer

THOMSON REUTERS
·
Apr 14

Harmony Biosciences - Reiterates 2026 Net Product Revenue Guidance of $1.0-$1.04 Bln

THOMSON REUTERS
·
Apr 14

Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Apr 14

Harmony Biosciences director Troy Ignelzi files initial beneficial ownership statement

Reuters
·
Apr 07

Harmony Biosciences announces annual shareholder meeting via webcast

Reuters
·
Apr 03

Harmony Biosciences appoints Anastasiou as Chief Operating Officer

TIPRANKS
·
Apr 02

Harmony Biosciences names Peter Anastasiou COO in executive reshuffle

Reuters
·
Apr 02

Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board

THOMSON REUTERS
·
Apr 02

Harmony Biosciences to present at Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 01

Harmony Biosciences Eyes Blockbuster Future After Record Year

TIPRANKS
·
Mar 05

Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval

Simply Wall St.
·
Feb 26

Oppenheimer Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC)

TIPRANKS
·
Feb 25

Harmony Biosciences Holdings, Inc. : Deutsche Bank Cuts Target Price to $30 From $31

THOMSON REUTERS
·
Feb 25

Harmony Biosciences Is Maintained at Buy by Needham

Dow Jones
·
Feb 25